Isotechnika Inc http://www.alacrastore.com/company-snapshot/Isotechnika_Inc-2105460 Tuesday, October 07, 2008 9:33:57 PM 2105460 Isotechnika Inc en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/PRN-0001-28276493newstex/PRN-0001-28276493xml Sep. ##, #### (Canada NewsWire Group delivered by Newstex) -- EDMONTON, Sept. ## /CNW/ -- (ISA:TSX): Isotechnika Inc. today announced Dr. Cantarovich, a principal investigator from the Company's recently completed Phase #b kidney transplant...0400000004002000040020061300000013001000130010029/24/2008 10:22:56 AM1800000018018000Canada NewsWire GroupPRN-0001-28276493ISOTECHNIKA INCISANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0001-27713803newstex/PRN-0001-27713803xml Aug. ##, #### (Canada NewsWire Group delivered by Newstex) -- EDMONTON, Aug. ## /CNW/ -- Isotechnika Inc. announced today that its Board of Directors has approved the engagement of Leerink Swann LLC and Deloitte to advise the Company...090000000901500004000000040020000400200604016000040160088/27/2008 6:18:51 PM180000001801800018022000Canada NewsWire GroupPRN-0001-27713803ISOTECHNIKA INCISANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0001-27211933newstex/PRN-0001-27211933xml Aug. #, #### (Canada NewsWire Group delivered by Newstex) -- EDMONTON, Aug. # /CNW/ -- Isotechnika Inc. announced today its financial results for the three and six months ended June ##, ####.Final results from the successfully completed...0700000007005000070100000400000004002000040020060401600004016018040160010401601307014000070140090200000002002000020020088/6/2008 1:19:46 PM180000001800400018018000180150001802200019000000190020001900201219002007Canada NewsWire GroupPRN-0001-27211933ISOTECHNIKA INCSILICON VALLEY BANCSHARESISASIVBNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0001-27072005newstex/PRN-0001-27072005xml EDMONTON, Jul. ##, #### (Canada NewsWire Group delivered by Newstex) -- /CNW/ -- (ISA:TSX): Isotechnika Inc. today announced that its partner, Lux Biosciences, presented preclinical data demonstrating the safety and pharmacokinetics...0400000004002000040020067/31/2008 11:23:40 AM1800000018018000Canada NewsWire GroupPRN-0001-27072005ISOTECHNIKA INCISANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0001-26813384newstex/PRN-0001-26813384xml EDMONTON, Jul. ##, #### (Canada NewsWire Group delivered by Newstex) -- /CNW/ -- (ISA:TSX): Isotechnika today announced that Roche has given up its rights to license voclosporin for solid organ transplant. This allows Isotechnika to...0400000004002000040020067/21/2008 4:15:50 PM1800000018018000Canada NewsWire GroupPRN-0001-26813384ISOTECHNIKA INCISANewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1868829ccbn/T1868829norm...Ladies and gentlemen, welcome to the Isotechnika conference call to discuss the final results from the Company's PROMISE trial evaluating voclosporin in de novo kidney transplant patients. Certain matters discussed in today's conference call, or answers that may be given to questions asked, could constitute forward-looking statements. Forward-looking statements, including the Company's belief of the potential of its product, the Company's expectations regarding the issuance of additional patents, and the Company's ability to protect its intellectual property involve know and unknown risks and uncertainties which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties includes among others the availability of funds and resources to pursue research and development projects. The ability to economically manufacture its products, the potential of its products, the success and timely completion of clinical studies... 6/4/2008 4:05:00 PMIsotechnika Inc.54.0000FinalIsotechnika Inc. Conference Call TranscriptISA.TO9:00am ETTranscriptT1868829Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1744073ccbn/T1744073norm1/17/2008 1:05:00 PMIsotechnika Inc.54.0000FinalIsotechnika to provide strategic update TranscriptISA.TO10:30am ET...Good morning, ladies and gentlemen, and welcome to the Isotechnika conference call to discuss the Company's corporate update on guidance regarding strategic direction and clinical development. Certain matters discussed in today's conference call or answers that may be given to questions asked could constitute forward-looking statements. Forward-looking statements, including the Company's belief as to the potential of its product, the Company's expectations regarding the issuance of additional patents, and the Company's ability to protect its intellectual property involve known and unknown risks and uncertainties which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include among others the availability of funds and resources to pursue research and development projects, the ability to economically manufacture its products, the potential of its products, the success and timely completion of clinical studies... TranscriptT1744073Credit & Investment ResearchThomson StreetEvents